# Concomitant Treatment of Permanent Atrial Fibrillation

> **NCT00566787** · PHASE3 · COMPLETED · sponsor: **AtriCure, Inc.** · enrollment: 39 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System

## Key facts

- **NCT ID:** NCT00566787
- **Lead sponsor:** AtriCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-12
- **Final completion:** 2010-11
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2012-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566787, "Concomitant Treatment of Permanent Atrial Fibrillation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00566787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*